Cargando…

Structure‐Activity Studies Reveal Scope for Optimisation of Ebselen‐Type Inhibition of SARS‐CoV‐2 Main Protease

The reactive organoselenium compound ebselen is being investigated for treatment of coronavirus disease 2019 (COVID‐19) and other diseases. We report structure‐activity studies on sulfur analogues of ebselen with the Severe Acute Respiratory Syndrome coronavirus 2 (SARS‐CoV‐2) main protease (M(pro))...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thun‐Hohenstein, Siegfried T. D., Suits, Timothy F., Malla, Tika R., Tumber, Anthony, Brewitz, Lennart, Choudhry, Hani, Salah, Eidarus, Schofield, Christopher J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015279/ https://www.ncbi.nlm.nih.gov/pubmed/34850566 http://dx.doi.org/10.1002/cmdc.202100582

Ejemplares similares

Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine
por: Malla, Tika R., et al.
Publicado: (2022)

2-Oxoglutarate derivatives can selectively enhance or inhibit the activity of human oxygenases
por: Nakashima, Yu, et al.
Publicado: (2021)

Fluorinated derivatives of pyridine-2,4-dicarboxylate are potent inhibitors of human 2-oxoglutarate dependent oxygenases
por: Brewitz, Lennart, et al.
Publicado: (2021)

In vitro selection of macrocyclic peptide inhibitors containing cyclic γ(2,4)-amino acids targeting the SARS-CoV-2 main protease
por: Miura, Takashi, et al.
Publicado: (2023)

Kinetic and inhibition studies on human Jumonji-C (JmjC) domain-containing protein 5
por: Tumber, Anthony, et al.
Publicado: (2023)

Synthesis of Novel Pyridine‐Carboxylates as Small‐Molecule Inhibitors of Human Aspartate/Asparagine‐β‐Hydroxylase
por: Brewitz, Lennart, et al.
Publicado: (2020)

Targeting the Mycobacterium tuberculosis transpeptidase Ldt(Mt2) with cysteine-reactive inhibitors including ebselen
por: de Munnik, Mariska, et al.
Publicado: (2019)

Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine
por: Brewitz, Lennart, et al.
Publicado: (2023)

Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS‐CoV‐2 Papain‐Like Protease
por: Brewitz, Lennart, et al.
Publicado: (2022)

Structure-guided optimisation of N-hydroxythiazole-derived inhibitors of factor inhibiting hypoxia-inducible factor-α
por: Corner, Thomas P., et al.
Publicado: (2023)

Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 M(pro) inhibitors
por: Malla, Tika R., et al.
Publicado: (2021)

Kinetic parameters of human aspartate/asparagine–β-hydroxylase suggest that it has a possible function in oxygen sensing
por: Brewitz, Lennart, et al.
Publicado: (2020)

Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease
por: Menéndez, Cintia A., et al.
Publicado: (2020)

Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
por: Amporndanai, Kangsa, et al.
Publicado: (2021)

Small-molecule active pharmaceutical ingredients of approved cancer therapeutics inhibit human aspartate/asparagine-β-hydroxylase
por: Brewitz, Lennart, et al.
Publicado: (2020)

Electrochemical Biosensor for the Detection of SARS-CoV-2 Main Protease and Its Inhibitor Ebselen
por: Zhang, Qiongyu, et al.
Publicado: (2022)

Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors
por: Brewitz, Lennart, et al.
Publicado: (2020)

Author Correction: Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors
por: Brewitz, Lennart, et al.
Publicado: (2020)

5-Substituted Pyridine-2,4-dicarboxylate Derivatives Have Potential for Selective Inhibition of Human Jumonji-C Domain-Containing Protein 5
por: Brewitz, Lennart, et al.
Publicado: (2023)

Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020)

Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020)

Allosteric Inhibition of the SARS‐CoV‐2 Main Protease: Insights from Mass Spectrometry Based Assays
por: El‐Baba, Tarick J., et al.
Publicado: (2020)

The Se–S Bond Formation in the Covalent Inhibition Mechanism of SARS-CoV-2 Main Protease by Ebselen-like Inhibitors: A Computational Study
por: Parise, Angela, et al.
Publicado: (2021)

Antibacterial Activity of Ebselen
por: Maślanka, Marta, et al.
Publicado: (2023)

Human Oxygenase Variants Employing a Single Protein Fe(II) Ligand Are Catalytically Active
por: Brasnett, Amelia, et al.
Publicado: (2021)

Substrate selectivity and inhibition of histidine JmjC hydroxylases MINA53 and NO66
por: Türkmen, Vildan A., et al.
Publicado: (2023)

Synthesis of 2-oxoglutarate derivatives and their evaluation as cosubstrates and inhibitors of human aspartate/asparagine-β-hydroxylase
por: Brewitz, Lennart, et al.
Publicado: (2020)

Detailed Insights into the Inhibitory Mechanism of New Ebselen Derivatives against Main Protease (M(pro)) of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
por: Sahoo, Pritiranjan, et al.
Publicado: (2022)

Combined proteomic and biochemical analyses redefine the consensus sequence requirement for epidermal growth factor-like domain hydroxylation
por: Brewitz, Lennart, et al.
Publicado: (2022)

Evaluation of SARS-CoV-2 main protease and inhibitor interactions using dihedral angle distributions and radial distribution function
por: Lamichhane, Tika Ram, et al.
Publicado: (2021)

The Potential Use of Ebselen in Treatment-Resistant Depression
por: Ramli, Fitri Fareez, et al.
Publicado: (2022)

Chemistry Related to the Catalytic Cycle of the Antioxidant Ebselen
por: Sands, Kai N., et al.
Publicado: (2023)

Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2
por: Weglarz-Tomczak, Ewelina, et al.
Publicado: (2021)

Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen
por: Favrot, Lorenza, et al.
Publicado: (2013)

Evaluation of ebselen supplementation on cryopreservation medium in human semen
por: Khodayari Naeini, Zohreh, et al.
Publicado: (2014)

Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections
por: Thangamani, Shankar, et al.
Publicado: (2015)

Convergent Synthesis of Two Fluorescent Ebselen-Coumarin Heterodimers
por: Küppers, Jim, et al.
Publicado: (2016)

Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)
por: AbdelKhalek, Ahmed, et al.
Publicado: (2018)

New Chiral Ebselen Analogues with Antioxidant and Cytotoxic Potential
por: Pacuła, Agata J., et al.
Publicado: (2017)

Micelle-embedded coating with ebselen for nitric oxide generation
por: Yang, Li, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_evrmqvlvommhfsdqsv7qg7i29l